cancer chemotherapy by prolonged arterialinfusionour current experience is reported with136 patients treated by prolonged arterialinfusion chemotherapy.  the patients pre-sented a variety of far advanced cancers un-suitable for conventional surgical or roent-gen therapy.  antimetabolite solution, eithermethotrexate or a fluorinated pyrimidine,was injected continuously through a smallplastic catheter into the unobstructed arteryto provide a high regional drug concentrationfor days to weeks.  the patients have receiveddrug infusion for up to 45 days.  their coursehas been followed for up to 37 months aftertreatment.methotrexate with antidote therapy bysystemic administration of citrovorum fac-tor was used preferentially in most patients.a fluorinated pyrimidine, most commonly,5-fluoro-2'-deoxyuridine, was preferred forhepatic artery infusion of liver metastases.